New Myelodysplastic Syndromes Findings from Institute of Hematology and Blood Diseases Hospital Published [Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic ...]

Source :: Stem Cell Week. December 18, 2023, 587
Publication Year :: 2023
Abstract: 2023 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- New research on myelodysplastic syndromes is the subject of a new report. According to [...]

Subjects :: Development and progression
Reports
Myelodysplastic syndromes -- Development and progression
Stem cells -- Reports
Hematopoietic stem cell transplantation -- Reports
Leukemia -- Development and progression
Stem cell research -- Reports
Decitabine -- Reports
Hematopoietic stem cells -- Transplantation

Tools